Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials. - Porter ML; Martorell A; Sayed CJ; Bechara FG; Lev-Tov H; Hsiao JL; Frew JW; Reguiaï Z; Gooderham MJ; Goldfarb N; van der Zee HH; Del Marmol V; et al. (Nature medicine, 2026)